Optimising prednisolone or prednisone replacement in adrenal insufficiency
Endocrine Connections · 26.07.2023 · 12 (8)
DOI: 10.1530/ec-23-0097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Connections, erschienen am 26.07.2023. Verfasst von Angelica Sharma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Context
Patients with adrenal insufficiency (AI) have a higher mortality than the general population, possibly because of excess glucocorticoid exposure at inappropriate times. The cortisol circadian rhythm is difficult to mimic with twice- or thrice-daily hydrocortisone. Prednisolone is a once-daily alternative which may improve patient compliance through its convenience.
Objectives
Prednisolone day curves can be used to accurately downtitrate patients to the minimum effective dose. This study aimed to review prednisolone day curves and determine therapeutic ranges at different time points after administration.
Methods
Between August 2013 and May 2021, 108 prednisolone day curves from 76 individuals receiving prednisolone replacement were analysed. Prednisolone concentrations were determined by ultra-high-performance liquid chromatography-tandem mass spectrometry. Spearman’s correlation coefficient was used to determine the relationship between 2-, 4-, and 6-h prednisolone levels compared to the previously validated standard 8-h prednisolone level (15–25 μg/L).
Results
The median dose was 4 mg of prednisolone once daily. There was a strong correlation between the 4- and 8-h ( R = 0.8829, P ≤ 0.0001) and 6- and 8-h prednisolone levels ( R = 0.9530, P ≤ 0.0001). Target ranges for prednisolone were 37–62 μg/L at 4 h, 24–39 μg/L at 6 h, and 15–25 μg/L at 8 h. Prednisolone doses were successfully reduced in 21 individuals, and of these, 3 were reduced to 2 mg once daily. All patients were well upon follow-up.
Conclusion
This is the largest evaluation of oral prednisolone pharmacokinetics in humans. Low-dose prednisolone of 2–4 mg is safe and effective in most patients with AI. Doses can be titrated with either 4-, 6-, or 8-h single time point drug levels.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
- Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
- Department of Clinical Biochemistry, North West London Pathology, London, UK.
ORCID-Profile: Angelica Sharma, Sirazum Choudhury
Zitieren
APA
Sharma, A., Lazarus, K., Papadopoulou, D., Prabhudev, H., Tan, T., Meeran, K., & Choudhury, S. (2023). Optimising prednisolone or prednisone replacement in adrenal insufficiency. Endocrine Connections, 12(8). https://doi.org/10.1530/ec-23-0097
Vancouver
Sharma A, Lazarus K, Papadopoulou D, Prabhudev H, Tan T, Meeran K, et al. Optimising prednisolone or prednisone replacement in adrenal insufficiency. Endocrine Connections. 2023;12(8). doi:10.1530/ec-23-0097
BibTeX
@article{Sharma2023,
author = {Sharma, Angelica and Lazarus, Katharine and Papadopoulou, Deborah and Prabhudev, Hemanth and Tan, Tricia and Meeran, Karim and Choudhury, Sirazum},
title = {Optimising prednisolone or prednisone replacement in adrenal insufficiency},
journal = {Endocrine Connections},
year = {2023},
volume = {12},
number = {8},
doi = {10.1530/ec-23-0097}
}
EUVIMED